Schrodinger, Inc. Revenue 2019-2024 | SDGR
Schrodinger, Inc. revenue from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Schrodinger, Inc. Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $217 |
| 2022 | $181 |
| 2021 | $138 |
| 2020 | $108 |
| 2019 | $86 |
| 2018 | $67 |
| Schrodinger, Inc. Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $35 |
| 2024-06-30 | $47 |
| 2024-03-31 | $37 |
| 2023-12-31 | $74 |
| 2023-09-30 | $43 |
| 2023-06-30 | $35 |
| 2023-03-31 | $65 |
| 2022-12-31 | $57 |
| 2022-09-30 | $37 |
| 2022-06-30 | $38 |
| 2022-03-31 | $49 |
| 2021-12-31 | $46 |
| 2021-09-30 | $30 |
| 2021-06-30 | $30 |
| 2021-03-31 | $32 |
| 2020-12-31 | $33 |
| 2020-09-30 | $26 |
| 2020-06-30 | $23 |
| 2020-03-31 | $26 |
| 2019-12-31 | $26 |
| 2019-09-30 | $20 |
| 2019-06-30 | $19 |
| 2019-03-31 | $21 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||